The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 344:381-382 February 1, 2001 Number 5
NextNext

Multiple Sclerosis

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
To the Editor: We are troubled by the suggestion in the review article on multiple sclerosis by Noseworthy and colleagues (Sept. 28 issue)1 that hepatitis B vaccine should be administered only to persons at substantial risk for exposure to the virus. The concern that hepatitis B vaccine may cause multiple sclerosis stems from case reports of demyelination beginning within months after vaccination. The World Health Organization and the Viral Hepatitis Prevention Board have reviewed preliminary results from ongoing controlled studies and other evidence. They have concluded that a causal association between hepatitis B immunization and demyelinating diseases of the central . . . [Full Text of this Article]

References



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.